Oxy
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline to market Lavipharm Labs' patented anti-blemish patch under Oxy brand in UK, pharmaceutical technology firm says. Marketing for Oxy Dots transparent patches will stress they reduce appearance of blemishes while targeting blocked pores and germs, Lavipharm says. Global distribution plans under consideration. Lavipharm's other cosmetic patch partners include L'Oreal, Chattem, Unilever, Vichy